Treatments for prostate cancer
If you have prostate cancer, your healthcare team will create a treatment plan just for you. It will be based on your health and specific information about the cancer. When deciding which treatments to offer for prostate cancer, your healthcare team will consider:
- the type and stage of the cancer
- the grade or Gleason score
- prostate-specific antigen (PSA) levels
- the risk group (whether it is likely that the cancer will come back after treatment)
- possible side effects of treatments
- your personal preferences
- your overall health and any existing medical conditions
- your age and life expectancy
- whether you have symptoms
Prostate cancer treatments can seriously affect your quality of life and cause side effects such as erectile dysfunction (problems getting or keeping an erection) and incontinence (loss of bladder control). Many prostate cancers grow slowly and cause no symptoms or problems.
American Cancer Society. Prostate Cancer. Atlanta, GA: American Cancer Society; 2015: http://www.cancer.org/acs/groups/cid/documents/webcontent/003134-pdf.pdf.
American Society of Clinical Oncology. Prostate Cancer. 2014: http://www.cancer.net/cancer-types/prostate-cancer/view-all.
Garnick MB (ed.). Harvard Medical School 2015 Annual Report on Prostate Diseases. 2015.
National Cancer Institute. Prostate Cancer Treatment (PDQ®). 2015: http://www.cancer.gov/types/prostate/patient/prostate-treatment-pdq.
National Cancer Institute. Prostate Cancer Treatment for Health Professionals (PDQ®). 2015: http://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (Version 1.2016). http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.
Princess Margaret Cancer Centre. Princess Margaret Cancer Centre Clinical Practice Guidelines: Prostate Cancer. 2015: http://www.uhn.ca/PrincessMargaret/Health_Professionals/Programs_Departments/Genitourinary_GU/Documents/CPG_GU_Prostate.pdf.
Saad F, Chi KN, Finelli A, Hotte SJ, Izawa J, Kapoor A, et al . The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC). Canadian Urological Association Journal. 2015: https://www.cua.org/themes/web/assets/files/guidelines/en/cua-cuog-guidelines.pdf.